Organism name | Panax ginseng |
---|---|
Genus | Panax |
Family | Araliaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Panax ginseng |
---|---|
Linked NCBI taxonomy ID | 4054 |
Linked level | species |
Family in NCBI taxonomy | Araliaceae |
---|---|
ID | 4050 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
Species | Activity |
---|---|
Panax ginseng C.A. Mey. | Adaptogen |
Panax ginseng C.A. Mey. | Adrenergic |
Panax ginseng C.A. Mey. | Alterative |
Panax ginseng C.A. Mey. | Analgesic |
Panax ginseng C.A. Mey. | Antiaggregant |
Panax ginseng C.A. Mey. | Antiaging |
Panax ginseng C.A. Mey. | Antialcoholic |
Panax ginseng C.A. Mey. | Antiarrhythmic |
Panax ginseng C.A. Mey. | Anticancer |
Panax ginseng C.A. Mey. | Anticatecholamine |
Panax ginseng C.A. Mey. | Anticholinergic |
Panax ginseng C.A. Mey. | Anticonvulsant |
Panax ginseng C.A. Mey. | Antidepressant |
Panax ginseng C.A. Mey. | Antidiuretic |
Panax ginseng C.A. Mey. | Antifatigue |
Panax ginseng C.A. Mey. | Antihepatomic |
Panax ginseng C.A. Mey. | Antiinflammatory |
Panax ginseng C.A. Mey. | Antiischemic |
Panax ginseng C.A. Mey. | Antimitogenic |
Panax ginseng C.A. Mey. | Antioxidant |
Panax ginseng C.A. Mey. | Antiprolactin |
Panax ginseng C.A. Mey. | Antiprostatic |
Panax ginseng C.A. Mey. | Antipsychotic |
Panax ginseng C.A. Mey. | Antiradiation |
Panax ginseng C.A. Mey. | Antiseptic |
Panax ginseng C.A. Mey. | Antithromboxane |
Panax ginseng C.A. Mey. | Antitumor |
Panax ginseng C.A. Mey. | Antiulcer |
Panax ginseng C.A. Mey. | Antiviral |
Panax ginseng C.A. Mey. | Antiwrinkle |
Panax ginseng C.A. Mey. | Anxiolytic |
Panax ginseng C.A. Mey. | Aperitif |
Panax ginseng C.A. Mey. | Aphrodisiac |
Panax ginseng C.A. Mey. | Apoptotic |
Panax ginseng C.A. Mey. | Bitter |
Panax ginseng C.A. Mey. | Cardiotonic |
Panax ginseng C.A. Mey. | Carminative |
Panax ginseng C.A. Mey. | Caspase Stimulator |
Panax ginseng C.A. Mey. | Chemopreventive |
Panax ginseng C.A. Mey. | Circulostimulant |
Panax ginseng C.A. Mey. | CNS Sedative |
Panax ginseng C.A. Mey. | CNS Stimulant |
Panax ginseng C.A. Mey. | Corticotrophinogenic |
Panax ginseng C.A. Mey. | Cytotoxic |
Panax ginseng C.A. Mey. | Demulcent |
Panax ginseng C.A. Mey. | Diuretic |
Panax ginseng C.A. Mey. | Elevates HDL-Cholesterol |
Panax ginseng C.A. Mey. | Emetic |
Panax ginseng C.A. Mey. | Energizer |
Panax ginseng C.A. Mey. | Estrogenic |
Panax ginseng C.A. Mey. | Ethanolytic |
Panax ginseng C.A. Mey. | Expectorant |
Panax ginseng C.A. Mey. | Fatigue |
Panax ginseng C.A. Mey. | Gonadotropic |
Panax ginseng C.A. Mey. | Hemopoietic |
Panax ginseng C.A. Mey. | Hepatoprotective |
Panax ginseng C.A. Mey. | Hepatotonic |
Panax ginseng C.A. Mey. | Hyperglycemic |
Panax ginseng C.A. Mey. | Hypertensive |
Panax ginseng C.A. Mey. | Hypocholesterolemic |
Panax ginseng C.A. Mey. | Hypoglycemic |
Panax ginseng C.A. Mey. | Hypotriglyceridemic |
Panax ginseng C.A. Mey. | Immunostimulant |
Panax ginseng C.A. Mey. | Interferonigenic |
Panax ginseng C.A. Mey. | Memorigenic |
Panax ginseng C.A. Mey. | Mineralcorticoid |
Panax ginseng C.A. Mey. | Mitogenic |
Panax ginseng C.A. Mey. | Negative Chronotropic |
Panax ginseng C.A. Mey. | Negative Inotropic |
Panax ginseng C.A. Mey. | Nervine |
Panax ginseng C.A. Mey. | Neurotonic |
Panax ginseng C.A. Mey. | Nicotinic |
Panax ginseng C.A. Mey. | NKC-Genic |
Panax ginseng C.A. Mey. | NO-Genic |
Panax ginseng C.A. Mey. | Nootropic |
Panax ginseng C.A. Mey. | Osteoprotective |
Panax ginseng C.A. Mey. | Phagocytotic |
Panax ginseng C.A. Mey. | Positive Inotropic |
Panax ginseng C.A. Mey. | Radioprotective |
Panax ginseng C.A. Mey. | Respirastimulant |
Panax ginseng C.A. Mey. | Roborant |
Panax ginseng C.A. Mey. | Secretagogue |
Panax ginseng C.A. Mey. | Sedative |
Panax ginseng C.A. Mey. | Serotonilytic |
Panax ginseng C.A. Mey. | Sialagogue |
Panax ginseng C.A. Mey. | Spermatogenic |
Panax ginseng C.A. Mey. | Stomachic |
Panax ginseng C.A. Mey. | Testosteronigenic |
Panax ginseng C.A. Mey. | Thymoleptic |
Panax ginseng C.A. Mey. | Tonic |
Panax ginseng C.A. Mey. | Tranquilizer |
Panax ginseng C.A. Mey. | Ulcerogenic |
Panax ginseng C.A. Mey. | Vasodilator |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00005157
![]() |
Panasenoside
|
CHEMBL500233
CHEMBL1375795 CHEMBL2032411 |
12 / 2 / 2 | No. 1 | No. 15 |
![]() |
||
C00030447
![]() |
Gypenoside XVII
|
CHEMBL504441
|
No. 11 | No. 51 |
![]() |
|||
C00030844
![]() |
Notoginsenoside Fe
|
No. 11 | No. 51 |
![]() |
||||
C00030398
![]() |
Ginsenoside Rd
|
CHEMBL473659
|
C049863
|
2 / 0 / 0 | 0 / 1 | No. 11 | No. 51 |
![]() |
C00031098
![]() |
Pseudoginsenoside F8
|
No. 11 | No. 51 |
![]() |
||||
C00003518
![]() |
Ginsenoside Re
|
CHEMBL510095
|
C049864
|
2 / 0 / 0 | 0 / 1 | No. 11 | No. 51 |
![]() |
C00033154
![]() |
Majoroside F4
|
No. 32 | No. 51 |
![]() |
||||
C00003520
![]() |
Ginsenoside Rg1
|
CHEMBL501637
CHEMBL1977916 |
C035054
|
5 / 6 | No. 32 | No. 51 |
![]() |
|
C00032815
![]() |
Ginsenoside F5
/ Chikusetsusaponin L8 |
CHEMBL583152
|
2 / 0 / 0 | No. 32 | No. 51 |
![]() |
||
C00032990
![]() |
Ginsenoside Rg7
|
No. 32 | No. 51 |
![]() |
||||
C00003519
![]() |
Ginsenoside Rf
|
CHEMBL1773987
|
C055328
|
1 / 0 | No. 32 | No. 51 |
![]() |
|
C00030399
![]() |
Panaxoside Rg2
/ Ginsenoside Rg2 |
CHEMBL505747
CHEMBL1095005 CHEMBL1095006 CHEMBL1475728 |
C026474
|
5 / 0 / 0 | 7 / 2 | No. 32 | No. 51 |
![]() |
C00033153
![]() |
Majoroside F2
|
No. 32 | No. 51 |
![]() |
||||
C00030390
![]() |
Ginsenoside F3
|
CHEMBL1095004
|
2 / 0 / 0 | No. 32 | No. 51 |
![]() |
||
C00030254
![]() |
Floralginsenoside A
|
No. 32 | No. 51 |
![]() |
||||
C00030255
![]() |
Floralginsenoside B
|
No. 32 | No. 51 |
![]() |
||||
C00030256
![]() |
Floralginsenoside C
/ (+)-Floralginsenoside C |
No. 32 | No. 51 |
![]() |
||||
C00030257
![]() |
Floralginsenoside D
|
No. 32 | No. 51 |
![]() |
||||
C00030258
![]() |
Floralginsenoside E
/ (+)-Floralginsenoside E |
No. 32 | No. 51 |
![]() |
||||
C00030389
![]() |
Ginsenoside F2
|
CHEMBL1095007
|
2 / 0 / 0 | No. 32 | No. 51 |
![]() |
||
C00030259
![]() |
Floralginsenoside F
/ (+)-Floralginsenoside F |
No. 32 | No. 51 |
![]() |
||||
C00030388
![]() |
Ginsenoside F1
|
CHEMBL584011
|
C055327
|
No. 99 |
![]() |
|||
C00032992
![]() |
Ginsenoside Rh6
/ (+)-Ginsenoside Rh6 |
No. 99 |
![]() |
|||||
C00032991
![]() |
Ginsenoside Rh5
|
CHEMBL454530
|
No. 99 |
![]() |
||||
C00032994
![]() |
Ginsenoside Rh8
/ (+)-Ginsenoside Rh8 |
No. 99 |
![]() |
|||||
C00032995
![]() |
Ginsenoside Rh9
|
No. 99 |
![]() |
|||||
C00032993
![]() |
Ginsenoside Rh7
/ (+)-Ginsenoside Rh7 |
No. 99 |
![]() |
|||||
C00021836
![]() |
Panasinsanol A
|
C053938
|
No. 161 | No. 38 |
![]() |
|||
C00021835
![]() |
Panasinsanol B
|
C053937
|
No. 161 | No. 38 |
![]() |
|||
C00021833
![]() |
beta-Panasinsene
/ beta-Panasinsanene |
No. 365 | No. 38 |
![]() |
||||
C00021834
![]() |
alpha-Panasinsanene
|
No. 365 | No. 38 |
![]() |
||||
C00021986
![]() |
beta-Neoclovene
|
No. 365 | No. 38 |
![]() |
||||
C00031489
![]() |
1,8-Heptadecadiene-4,6-diyne-3,10-diol
|
CHEMBL463807
CHEMBL448210 |
C056818
|
No. 940 | No. 69 |
![]() |
||
C00001284
![]() |
Panaxynol
/ Falcarinol / (-)-Falcarinol |
CHEMBL71260
CHEMBL368712 |
C018541
|
0 / 2 | No. 940 | No. 69 |
![]() |
|
C00002682
![]() |
Vanillic acid
/ 3-Methoxy-4-hydroxybenzoic acid |
CHEMBL120568
|
D014641
|
5 / 3 / 3 | 5 / 0 | No. 1073 |
![]() |
|
C00000100
![]() |
IAA
/ Indole-3-acetic acid |
CHEMBL82411
|
C030737
|
3 / 0 / 0 | 2 / 1 | No. 1432 | No. 4 |
![]() |
C00030922
![]() |
Panaxydol
/ (-)-Panaxydol |
C055778
|
6 / 1 | No. 3682 |
![]() |
|||
C00000101
![]() |
IAA methyl ester
/ Methyl indole-3-acetate |
No. 4225 |
![]() |
|||||
C00001756
![]() |
Perlolyrine
/ Tribulusterine |
CHEMBL501991
|
C055781
|
No. 5379 | No. 4 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P11387 | DNA topoisomerase 1 | Isomerase | C00003518 C00030389 C00030390 C00030398 C00030399 C00032815 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003518 C00030389 C00030390 C00030398 C00030399 C00032815 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00002682 C00005157 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00005157 C00030399 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00002682 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00005157 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00005157 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00005157 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00005157 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00002682 | 1 / 1 |
Q16773 | Kynurenine--oxoglutarate transaminase 1 | Enzyme | C00000100 | 0 / 0 |
P02768 | Serum albumin | Secreted protein | C00000100 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00005157 | 1 / 1 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00030399 | 0 / 0 |
Q9HBH1 | Peptide deformylase, mitochondrial | Enzyme | C00000100 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00030399 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00002682 | 1 / 1 |
P51580 | Thiopurine S-methyltransferase | Enzyme | C00002682 | 1 / 1 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00005157 | 1 / 1 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00005157 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00005157 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00005157 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00005157 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
3757 | KCNH2, ERG1, HERG, HERG1, Kv11.1, LQT2, SQT1 | potassium voltage-gated channel, subfamily H (eag-related), member 2 |
C00003519
C00003520
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00003520
C00030922
|
200186 | CRTC2, TORC-2, TORC2 | CREB regulated transcription coactivator 2 |
C00030399
|
8431 | NR0B2, SHP, SHP1 | nuclear receptor subfamily 0, group B, member 2 |
C00030399
|
5105 | PCK1, PEPCK-C, PEPCK1, PEPCKC | phosphoenolpyruvate carboxykinase 1 (soluble) (EC:4.1.1.32) |
C00030399
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00030399
|
6794 | STK11, LKB1, PJS, hLKB1 | serine/threonine kinase 11 (EC:2.7.11.1) |
C00030399
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000100
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00000100
|
898 | CCNE1, CCNE | cyclin E1 |
C00003520
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00003520
|
92579 | G6PC3, SCN4, UGRP | glucose 6 phosphatase, catalytic, 3 (EC:3.1.3.9) |
C00030399
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00030399
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00003520
|
174 | AFP, FETA, HPAFP | alpha-fetoprotein |
C00030922
|
213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00030922
|
3397 | ID1, ID, bHLHb24 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
C00030922
|
3398 | ID2, GIG8, ID2A, ID2H, bHLHb26 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
C00030922
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00030922
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00002682
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00002682
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00002682
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00002682
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00002682
|
OMIM | preferred title | UniProt |
---|---|---|
#615363 | Estrogen resistance; estrr |
P03372
|
#232300 | Glycogen storage disease ii |
P10253
|
#143100 | Huntington disease; hd |
P42858
|
#610460 | Thiopurine s-methyltransferase deficiency |
P51580
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00964 | Thiopurine S-methyltransferase deficiency (TPMT deficiency) |
P51580
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D006948 | Hyperkinesis |
C00030399
C00003520 C00003518 |
D003928 | Diabetic Nephropathies |
C00003520
|
D019970 | Cocaine-Related Disorders |
C00030399
|
D002545 | Brain Ischemia |
C00001284
|
D056486 | Drug-Induced Liver Injury |
C00000100
|
D003704 | Dementia |
C00003520
|
D015427 | Reperfusion Injury |
C00001284
|
D007249 | Inflammation |
C00003520
|
D007859 | Learning Disorders |
C00003520
|
D008569 | Memory Disorders |
C00003520
|
D007674 | Kidney Diseases |
C00030398
|
D006528 | Carcinoma, Hepatocellular |
C00030922
|